Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap.

Erfani, Parsa; Bates, Michael; Garcia-Gonzalez, Pat; Milner, Dan A; Rebbeck, Timothy R; Ruhangaza, Deogratias; Shulman, Lawrence N; Fadelu, Temidayo

Erfani, Parsa; Bates, Michael; Garcia-Gonzalez, Pat; Milner, Dan A; Rebbeck, Timothy R; Ruhangaza, Deogratias; Shulman, Lawrence N; Fadelu, Temidayo.

Afiliación

Erfani P; Harvard Medical School, Boston, MA.
Bates M; Medical and Scientific Affairs, Oncology, Cepheid, Sunnyvale, CA.
Garcia-Gonzalez P; The Max Foundation, Global Headquarters, Seattle, WA.
Milner DA; American Society for Clinical Pathology, Chicago, IL.
Rebbeck TR; Harvard TH Chan School of Public Health, Boston, MA.
Ruhangaza D; Harvard TH Chan School of Public Health, Boston, MA.
Shulman LN; Department of Pathology, Butaro Cancer Center of Excellence, Burera, Rwanda.
Fadelu T; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

JCO Glob Oncol ; 8: e2200182, 2022 10.

Article en En | MEDLINE | ID: mdl-36252158

Asunto(s)

Neoplasias; Patología Molecular; Humanos; Neoplasias/diagnóstico; Neoplasias/terapia; Tecnología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Patología Molecular / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: JCO Glob Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google